Affordable healthcare threatened! Concern for all stakeholders

The outrageous price rise of the 62-year-old drug, Daraprim (Pyrimethamine) has sent the United States medical fraternity into a dizzy. The price of the drug was raised from USD 13.50 to USD 750 per pill in just over a month. This obnoxious price rise of over 5,000% came after the New York-based pharmaceutical company Turing Pharmaceuticals acquired the patent for the drug from Impax Laboratories. (Editorial)

Original Source

blog comments powered by Disqus